BridgeMD
New treatment option for Fluid Refractory Septic Shock
Official title Adrenaline V/s Dopamine in Fuid Refractory Septic Shock
ClinicalTrials.gov ID: NCT07273526
What this study is testing
What is Adrenaline?
Adrenaline is an investigational medicine, being studied as a potential treatment for fluid refractory septic shock.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study compares the efficacy of two drugs i.e Adrenaline and dopamine in fluid refractory type of septic shock which is a dreadful medical condition especially in children. The efficacy will be checked based on heart rate , GCS, capillary refill time , palpable pripheral pulse , urine output and systolic blood pressure.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 12
You may be able to join if
- Patients of both Genders having age range between 1month and 12 years with diagnosis of fluid refractory septic shock as per operational definition.
You likely can't join if
- Patients with
- cardiopumonary Bypass during last 5 days
- Chronic Systemic disease like Chronic kidney Disease , cerebral palsy, congenital heart disease
- neuromuscular discorder
- Metabolic disorders
- Those who already had treatment at periphery for hypovolemia without any record of medication or sequential organ failure at presentation
The study team makes the final eligibility decision.
Where it's taking place
- Faisalābad, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 month to 12 months. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Faisalābad, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.